CHRISTINE DEANDREA: Open Payments
NPI 1821627209 · UPPER ST CLAIR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,070 in 47 payments from 9 companies in 2025. Trend: 2023 $1,055 · 2024 $878 · 2025 $1,070
Food & beverage: $959Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $242 |
| Otsuka America Pharmaceutical, Inc. | 12 | $239 |
| Teva Pharmaceuticals USA, Inc. | 4 | $163 |
| Alkermes, Inc. | 5 | $108 |
| Lundbeck LLC | 5 | $86 |
| Janssen Pharmaceuticals, Inc | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
Products named: REXULTI, VRAYLAR, ARISTADA, INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA, Jornay PM, Qelbree.
Industry payments across PA — which companies pay providers there.
